178 related articles for article (PubMed ID: 30267762)
1. Bortezomib and endocannabinoid/endovanilloid system: a synergism in osteosarcoma.
Punzo F; Tortora C; Di Pinto D; Pota E; Argenziano M; Di Paola A; Casale F; Rossi F
Pharmacol Res; 2018 Nov; 137():25-33. PubMed ID: 30267762
[TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human osteosarcoma.
Punzo F; Tortora C; Di Pinto D; Manzo I; Bellini G; Casale F; Rossi F
Oncotarget; 2017 Aug; 8(33):54459-54471. PubMed ID: 28903355
[TBL] [Abstract][Full Text] [Related]
3. The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma.
Rossi F; Tortora C; Punzo F; Bellini G; Argenziano M; Di Paola A; Torella M; Perrotta S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003519
[TBL] [Abstract][Full Text] [Related]
4. Effects of CB2 and TRPV1 receptors' stimulation in pediatric acute T-lymphoblastic leukemia.
Punzo F; Manzo I; Tortora C; Pota E; Angelo V; Bellini G; Di Paola A; Verace F; Casale F; Rossi F
Oncotarget; 2018 Apr; 9(30):21244-21258. PubMed ID: 29765535
[TBL] [Abstract][Full Text] [Related]
5. PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity.
Bellini G; Torella M; Manzo I; Tortora C; Luongo L; Punzo F; Colacurci N; Nobili B; Maione S; Rossi F
Pharmacol Res; 2017 Jan; 115():267-274. PubMed ID: 27919827
[TBL] [Abstract][Full Text] [Related]
6. Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva).
Darmani NA; Chebolu S; Zhong W; Trinh C; McClanahan B; Brar RS
Eur J Pharmacol; 2014 Jan; 722():147-55. PubMed ID: 24157976
[TBL] [Abstract][Full Text] [Related]
7. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
[TBL] [Abstract][Full Text] [Related]
8. ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.
Luo J; Xia Y; Yin Y; Luo J; Liu M; Zhang H; Zhang C; Zhao Y; Yang L; Kong L
Theranostics; 2019; 9(21):6334-6353. PubMed ID: 31534554
[No Abstract] [Full Text] [Related]
9. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy.
Rossi F; Bellini G; Luongo L; Torella M; Mancusi S; De Petrocellis L; Petrosino S; Siniscalco D; Orlando P; Scafuro M; Colacurci N; Perrotta S; Nobili B; Di Marzo V; Maione S;
Bone; 2011 May; 48(5):997-1007. PubMed ID: 21237298
[TBL] [Abstract][Full Text] [Related]
10. GRP78 inhibition enhances ATF4-induced cell death by the deubiquitination and stabilization of CHOP in human osteosarcoma.
Luo J; Xia Y; Luo J; Li J; Zhang C; Zhang H; Ma T; Yang L; Kong L
Cancer Lett; 2017 Dec; 410():112-123. PubMed ID: 28947141
[TBL] [Abstract][Full Text] [Related]
11. Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response.
Beider K; Rosenberg E; Dimenshtein-Voevoda V; Sirovsky Y; Vladimirsky J; Magen H; Ostrovsky O; Shimoni A; Bromberg Z; Weiss L; Peled A; Nagler A
J Hematol Oncol; 2020 Nov; 13(1):158. PubMed ID: 33239060
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels.
Fatahi Z; Reisi Z; Rainer G; Haghparast A; Khani A
Neuropharmacology; 2018 May; 133():75-84. PubMed ID: 29355640
[TBL] [Abstract][Full Text] [Related]
13. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
14. Kuanoniamine C stimulates bortezomib-induced cell death via suppression of glucose-regulated protein 78 in osteosarcoma.
Machihara K; Namba T
Biochem Biophys Res Commun; 2020 Jun; 527(1):289-296. PubMed ID: 32446382
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide rewires mantle cell lymphoma response to bortezomib.
Zhao LL; Liu YF; Peng LJ; Fei AM; Cui W; Miao SC; Hermine O; Gressin R; Khochbin S; Chen SJ; Wang J; Mi JQ
Cancer Med; 2015 Nov; 4(11):1754-66. PubMed ID: 26310857
[TBL] [Abstract][Full Text] [Related]
19. Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.
Curto-Reyes V; Llames S; Hidalgo A; Menéndez L; Baamonde A
Br J Pharmacol; 2010 Jun; 160(3):561-73. PubMed ID: 20233215
[TBL] [Abstract][Full Text] [Related]
20. [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism].
Qu F; Xia B; Li X; Guo S; Zhang L; Tian C; Yu Y; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):412-7. PubMed ID: 26463142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
